
Stateam is a specialized service provider in the biotechnology and clinical development industry offering a comprehensive range of services including biostatistics, data analytics, statistical programming, quality assurance, regulatory consulting, and pharmacovigilance. The company supports clients through the entire clinical development spectrum with expertise in strategic consulting, Real World and External Control Designs, CDISC implementation, medical writing, regulatory submission strategy and FDA representation. Stateam leverages advanced technologies such as SAS programming, AI, machine learning, and natural language processing to enhance data quality, regulatory compliance, and pharmacovigilance efficiency. Their business model is service-based, focusing on delivering quality, timely, and budget-conscious solutions to pharmaceutical and healthcare clients, aiming to improve public health outcomes and ensure regulatory success.

Stateam is a specialized service provider in the biotechnology and clinical development industry offering a comprehensive range of services including biostatistics, data analytics, statistical programming, quality assurance, regulatory consulting, and pharmacovigilance. The company supports clients through the entire clinical development spectrum with expertise in strategic consulting, Real World and External Control Designs, CDISC implementation, medical writing, regulatory submission strategy and FDA representation. Stateam leverages advanced technologies such as SAS programming, AI, machine learning, and natural language processing to enhance data quality, regulatory compliance, and pharmacovigilance efficiency. Their business model is service-based, focusing on delivering quality, timely, and budget-conscious solutions to pharmaceutical and healthcare clients, aiming to improve public health outcomes and ensure regulatory success.